early 1980s there was increasing concern about Upjohn
revenues and profits, which were being maintained only
because of tax-favorable treatment in the Puerto Rico
manufacturing plant. The document below summarizes the
turnaround strategy created in 1984. The slides after the
document give some interesting information about the pharma
industry in the early 1980s.